STOCK TITAN

Medical Care Techs (MDCE) Stock News

MDCE OTC

Medical Care Technologies Inc. develops and commercializes artificial intelligence applications across consumer software, imaging analysis, healthcare-oriented pre-screening and collectibles authentication. News about MDCE centers on its AI technology stack, including Snapshot Recipes, a mobile recipe application with AI-generated food and beverage content, and Real Game Used, a subsidiary developing a patent-pending AI authentication platform for sports memorabilia.

Company updates also cover AI imaging initiatives for dermatological analysis, wellness monitoring, product verification and automated quality control, as well as capital and asset-monetization activity through Infinite Auctions. Recurring announcements describe product redesigns, commercialization pathways, subsidiary activity, mobile-app user growth initiatives, and enterprise API or visual analytics use cases.

Rhea-AI Summary

Medical Care Technologies (MDCE) reported a 270% rise in third-quarter net income while continuing paid software development and subsidiary collectibles operations. Unaudited results for the quarter ended September 30, 2026 showed net income of $192,565, versus $52,103. Revenue rose 13% to $538,981, gross profit increased 55% to $240,839, and net operating income rose 254% to $192,565. Nine-month net income reached $198,883 versus a prior-year loss of $145,347. Current liabilities were zero at quarter-end.

Development continues under its first paid external software agreement, worth up to $250,000. Subsidiary collectibles partnership activity has reached six figures, and Real Game Used maintains an authentication backlog. Subsidiaries manage approximately $20 million in private collectibles assets; potential net profits depend on completed sales. MDCE also expanded into enterprise consulting for AI model training.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Medical Care Technologies (OTCID:MDCE) reported third-quarter net income growth of 270% in unaudited results for the period ended September 30, 2026. Net income reached $192,565, versus $52,103 a year earlier. Revenue increased 13% to $538,981 from $478,128, while gross profit rose 55% to $240,839 from $155,720. Net operating income increased 254% to $192,565 from $54,370.

For the nine months ended September 30, 2026, net income was $198,883, compared with a prior-year net loss of $145,347. Nine-month gross profit increased to $332,744 from $78,042. The company ended the quarter with zero current liabilities and cash of $102,172.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
none
-
Rhea-AI Summary

Medical Care Technologies (OTCID:MDCE) announced that its subsidiaries are managing approximately $20 million in privately held collectibles assets. Real Game Used is authenticating the items, while Infinite Auctions is positioned to sell them through its auction platform.

The company estimates potential net profits just above $5 million if all assets sell at levels consistent with current market interest. That outcome depends on completed sales and is not guaranteed. Its software agreement announced October 14, StrainScan Pro demonstrations and health imaging activities remain separate from the collectibles arrangement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
none
Rhea-AI Summary

Medical Care Technologies (MDCE) outlined its software and subsidiary operations, including a first paid external enterprise agreement worth up to $250,000. Development is underway on an integrated inventory and sales system, and the company has expanded into AI model-training and software-integration consulting.

Full-year 2025 revenue was $1,071,812, with net income of $230,768. The company expects third-quarter 2026 results in the coming weeks to show its strongest quarterly revenue of the past year. Infinite Auctions and Real Game Used remain revenue contributors. Two health-imaging applications remain in internal testing and development without regulatory clearance. MDCE raised its Reg A offering price 100% to $0.00012 and plans further increases based on stock-price strength.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
none
-
Rhea-AI Summary

Medical Care Technologies (OTCID:MDCE) has begun development under its first paid external software agreement outside its subsidiaries, valued at up to $250,000.

The agreement, announced October 14, involves a client group that includes current and retired professional athletes. The first payment has been initiated, but is not described as received. Work covers an integrated web and enterprise software system, with consulting and administrative support during development, testing and deployment.

Separately, the company says a subsidiary is in the process of completing the largest agreement in the history of Medical Care Technologies and its subsidiaries. That agreement is not yet complete. Other work includes enterprise consulting for AI model training and internal evaluation of MDCE Melanoma Scan Beta and a wound-monitoring application.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
none
-
Rhea-AI Summary

Medical Care Technologies (MDCE) published updated internal technical evaluation results for Melanoma Scan Beta using an expanded human-submitted image dataset.

In controlled sequential captures, 86% of newly submitted photographs met the usability threshold, 89% of usable images were successfully placed on the body map, and 91% of paired sequential images achieved alignment for visual review. End-to-end completion without manual intervention was 84%. The company reported higher usability and registration results than in its first pass.

The results assess image handling, mapping and comparison, not clinical efficacy. The product remains in beta development without regulatory clearance, and volunteer image intake remains open.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
none
Rhea-AI Summary

Medical Care Technologies (OTCID:MDCE) highlighted revenue growth and its first external AI software agreement, valued at up to $250,000.

Fiscal 2025 revenue reached approximately $1.07 million, up 63% year over year, while net income increased 53% to $230,768. Management expects third-quarter 2026 revenue to exceed each of the preceding four quarters. The commercial relationship with Topps generated six-figure business activity in the initial month of the sales arrangement.

For the remainder of 2026 and into 2027, MDCE plans to prioritize revenue-producing opportunities, enterprise software commercialization and expanded subsidiary operations. Future financing and capital-structure decisions will depend on operational requirements, market conditions, available alternatives and applicable legal and contractual requirements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
AI
-
Rhea-AI Summary

Medical Care Technologies (MDCE) announced that subsidiary Real Game Used maintains a steady backlog of authentication work from customers and auction brands. The subsidiary recently launched an automated website submission system that lets customers initiate authentication requests online. Real Game Used remains an active revenue contributor within MDCE's broader operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
none
-
Rhea-AI Summary

Medical Care Technologies (MDCE) is working with task-based software technicians and external platforms to support technology and enterprise-services expansion. The work covers model refinement, integration, workflow development and platform scaling. Its first paid external software agreement is valued at up to $250,000. Subsidiaries Infinite Auctions and Real Game Used have also reached six figures in partnership activity within the arrangement's first few weeks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
none
Rhea-AI Summary

Medical Care Technologies (MDCE) is expanding beyond AI software sales to provide businesses with AI model training and software integration consulting. Services include data preparation guidance, integration design and repeated model refinement.

The transition follows its first paid external software agreement, announced October 14, valued at up to $250,000 with a client group including current and retired NFL players. Subsidiaries Infinite Auctions and Real Game Used have also advanced a collectibles partnership that reached six figures in activity within its first few weeks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
AI

FAQ

What is the current stock price of Medical Care Techs (MDCE)?

Medical Care Techs (MDCE) last closed at $0.0001.

What is the market cap of Medical Care Techs (MDCE)?

The market cap of Medical Care Techs (MDCE) is approximately $325.0K.